Product Information
DOXAZOSIN MESYLATE 1 MG TAB is a generic product labeled by Mylan Pharmaceuticals Inc., priced at $0.0779 per EA under NDC 59762241007. Its NADAC has been published 218 times since Mar 23, 2022.
FDA first approved this application on Nov 2, 1990. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
The High Outlier badge above means this manufacturer's average price in the doxazosin market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
1 mg/1
Manufacturer
Mylan Pharmaceuticals Inc.NDC
59762241007
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
5/20/2026
Active Ingredients
DOXAZOSIN MESYLATEApproval Type
Authorized Generic (NDA)
FDA Application
NDA019668FDA Approved
11/2/1990
TE Code
AB
On Market Since
11/3/2021
Pharmacological Classes
Price Statistics
The NADAC for DOXAZOSIN MESYLATE 1 MG TAB has been published 218 times since Mar 23, 2022, and over the history we have for it it has declined 17.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0779 per EA |
|---|---|
| All-time high | $0.1037 (Dec 14, 2022) |
| All-time low | $0.0632 (Jan 18, 2023) |
| 52-week high | $0.0856 |
| 52-week low | $0.0766 |
| Median price | $0.0810 |
| Average price | $0.0803 |
| Largest weekly change | +55.9% (Feb 22, 2023) |
| Weeks tracked | 218 |
| Tracking since | Mar 23, 2022 |
1W
N/A
1M
N/A
3M
N/A
6M
-6.8%
1Y
-7.5%
3Y
-7.0%
5Y
N/A
All
-17.1%
Last surveyed May 20, 2026 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the doxazosin market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of DOXAZOSIN MESYLATE 1 MG TAB?
The current National Average Drug Acquisition Cost (NADAC) for DOXAZOSIN MESYLATE 1 MG TAB, manufactured by Mylan Pharmaceuticals Inc., is $0.0779 per EA (NDC 59762241007), effective May 20, 2026.
How has the price of DOXAZOSIN MESYLATE 1 MG TAB changed over time?
Over the history we have for it, the NADAC for DOXAZOSIN MESYLATE 1 MG TAB has declined 17.1%. It has been tracked across 218 weekly CMS publications since Mar 23, 2022.
What are the highest and lowest recorded NADAC prices for DOXAZOSIN MESYLATE 1 MG TAB?
Since Mar 23, 2022, the NADAC for DOXAZOSIN MESYLATE 1 MG TAB has ranged from a low of $0.0632 (Jan 18, 2023) to a high of $0.1037 (Dec 14, 2022), with a median of $0.0810 per EA.
Are there cheaper alternatives to DOXAZOSIN MESYLATE 1 MG TAB?
No other NADAC-published product currently shares the active ingredient and strength of DOXAZOSIN MESYLATE 1 MG TAB in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures DOXAZOSIN MESYLATE 1 MG TAB?
DOXAZOSIN MESYLATE 1 MG TAB (NDC 59762241007) is labeled by Mylan Pharmaceuticals Inc., and CMS classifies it as a generic product.